• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

For Consumers

  • Print
  • Share
  • E-mail

July 13 Webinar—FDA’s Safety Monitoring of Approved Vaccines

Red envelope icon for Govdelivery Get Consumer Updates by E-mail

RSS feed orange symbol Consumer Updates RSS Feed

Did you know the Food and Drug Administration (FDA) continues to review vaccine safety even after a vaccine is approved?

Learn more when FDA’s Center for Biologics Evaluation and Research hosts a 30-minute webinar on the agency’s efforts to ensure the safety of vaccines.

During the webinar, FDA will give an overview of vaccine safety surveillance, including the Vaccine Adverse Event Reporting System (VAERS) and efforts underway to improve safety monitoring. FDA is working with federal, international, academic, and health care partners to improve its ability to evaluate the safety of vaccines.

There will be an opportunity to ask questions following the presentation.

When:  Tuesday, July 13, 2010, at 2:00 p.m. EDT

Where: To join the webinar, see the instructions at http://www.fda.gov/AboutFDA/Transparency/Basics/ucm218083.htm. Webinar materials will also be available there.

Host:  FDA’s Center for Biologics Evaluation and Research

          phone: 1-800-835-4709

          e-mail: ocod@fda.hhs.gov

Featured speaker: Andrea Sutherland, M.D., M.P.H., M.Sc., is a medical officer and special assistant to the director of the Division of Epidemiology in the Office of Biostatistics and Epidemiology within FDA’s Center for Biologics Evaluation and Research.

This webinar is the sixth in a series of monthly online sessions hosted by different FDA centers and offices. The series is part of FDA Basics, a Web-based resource aimed at helping the public better understand what the agency does.

This article appears on FDA's Consumer Updates page, which features the latest on all FDA-regulated products.

Posted July 7, 2010

back to top

-

For More Information

-